Fig. 6.
Effect of RARα-, β-, and γ-receptor–selective retinoids in combination with a RXR-receptor–selective retinoid on TGase II activity in RPMI 8226 cells. Cells were treated for 48 hours with either 10−7 mol/L atRA or 10−7mol/L CD2425 (RXR selective) and various doses of Am580 (RARα selective), CD417 (RARβ selective), or CD437 (RARγ selective) in defined medium for 7 hours, and then in 3% FCS-supplemented medium.
